Clinical Trials Logo

Clinical Trial Summary

Neuronal injury is evident in elective craniotomy for space occupying lesions. Surgical trauma and mechanichal impact of the tumor causes neuronal injury. Neurosreroid progesterone is a neurotransmittern , trail to use in abolishing neurotoxcicty


Clinical Trial Description

Progesterone is a natural neurosteroid that we are trying to use to impede both direct neuronal injury cauesd by and indirectly by surgical trauma. Progesterone can decreas vasogenic brain oedema. Our primary outcome is to ameliorate microscopic cytoplasmic injury and decrease brain oedema exploited by biopsy from brain tumor interface. Exclusion criteria demonstratd as refusal to participate in the trial , emergency craniotomy, recurrent brain tumor. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04414020
Study type Interventional
Source Minia University
Contact Mina Raouf, MD
Phone 01015752424
Email drmina2015@gmail.com
Status Recruiting
Phase Phase 1
Start date June 1, 2020
Completion date September 30, 2020